Trinity College Dublin has launched the Trinity Centre for Reproductive Sciences and Women's Health (TCRW), its first dedicated transdisciplinary centre for women's and reproductive health. Opened on 12 October 2026 by Minister for Health Jennifer Carroll MacNeill, it brings together more than 70 researchers across 20 disciplines, based at St James's Hospital.
The centre is hosted by the Trinity Translational Medicine Institute (TTMI) at St James's Hospital, where it was launched, according to the Trinity announcement. It links clinicians, scientists, social scientists and policy researchers at Trinity and its clinical partners: St James's Hospital, Tallaght University Hospital, the Coombe Women and Infants University Hospital, and Children's Health Ireland at Crumlin.
- Launched: 12 October 2026 by Minister for Health Jennifer Carroll MacNeill TD.
- Scale: more than 70 researchers across 20 disciplines.
- Home: Trinity Translational Medicine Institute at St James's Hospital, Dublin.
- Partners: St James's, Tallaght University Hospital, the Coombe, and Children's Health Ireland at Crumlin.
- Focus: conditions including PMOS (formerly PCOS), endometriosis, infertility, menopause and abnormal uterine bleeding, plus male reproductive health.
- Funding: no funder or budget was announced.
What the new centre will do
Trinity describes the centre's work under five objectives: research; shaping clinical practice and policymaking; dedicated policy brokerage and structured engagement; education and training; and public engagement and visibility. The research is organised in three pillars, with inclusion, equity and access running across all of them.
| Structure | As set out by Trinity |
|---|---|
| Research pillars | Translational Reproductive Science; Lifespan Reproductive Research; Menstrual Disorders and Fertility |
| Cross-cutting theme | Inclusion, equity and access |
| Objective areas | Research; clinical practice and policymaking; policy brokerage and engagement; education and training; public engagement |
| Hosted by | Trinity Translational Medicine Institute, St James's Hospital |
The conditions named at the launch are polyendocrine metabolic ovarian syndrome (PMOS), the new name for what was known as polycystic ovary syndrome (PCOS); endometriosis; infertility; menopause-related health needs; and abnormal uterine bleeding. Male reproductive health and subfertility are also within scope. The centre says it will work closely with patient representatives and advocacy groups.
Who leads TCRW
The centre has three co-directors:
- Professor Cliona O'Farrelly, Professor of Comparative Immunology at the Trinity Biomedical Sciences Institute.
- Dr Lisa Owens, Consultant Endocrinologist at St James's Hospital and Clinical Senior Lecturer at Trinity.
- Dr Michelle Lavin, Consultant Haematologist at the National Coagulation Centre, St James's Hospital.
"TCRW will bring together expertise across reproductive sciences and women's health to create a more connected and collaborative research community," said Dr Owens. "The measure of our success will not simply be publications or research grants; ultimately, it will be improved evidence, earlier diagnosis, better treatments, more equitable healthcare and better outcomes for people affected by reproductive health conditions."
What the Minister and partners said
"We know that, for sustained improvements in reproductive and women's health, we need to build research infrastructure to generate the evidence on which those services are based," said Minister Carroll MacNeill. "This centre will have a real impact on evidence gaps and delayed diagnosis and I look forward to continuing to engage with the centre as we - together - work to improve our health services."
Mary Day, Chief Executive of St James's Hospital, said the centre "exemplifies the ambition of an Academic Health Sciences Campus: connecting research and clinical care, working collaboratively across traditional boundaries, and creating a cohesive academic focus that can translate discovery into meaningful improvements in care and outcomes."
Professor Padraic Fallon, Dean of the Faculty of Health Sciences, said the centre "will connect and coordinate the considerable activity already underway across the University and its clinical partners, strengthen national and international collaborations, increase our competitiveness for major research funding, and enhance the visibility and impact of Trinity's research in this field."
Why it matters
Delayed diagnosis is a recurring problem in women's health; endometriosis in particular is often diagnosed years after symptoms begin. The Minister's emphasis on "evidence gaps and delayed diagnosis" points to where the centre is expected to make a difference. By joining researchers who were previously spread across separate departments and hospitals, TCRW gives Trinity a single point of contact for collaborators, patient groups and funders.
For Ireland's research and life-science community, the centre also creates a clearer route for clinical studies in women's health. Fallon's comment that it should make Trinity more competitive for major research funding suggests that new funding bids are a near-term priority.
What was not announced
Trinity did not name a funder or a budget for the centre, and it did not announce a new building or new posts. The centre is a coordinating structure hosted by TTMI, built on research activity that already exists across Trinity and its partner hospitals.
Frequently Asked Questions (FAQ)
Q: What is TCRW?
A: The Trinity Centre for Reproductive Sciences and Women's Health, Trinity College Dublin's first dedicated transdisciplinary centre for women's and reproductive health, launched on 12 October 2026.
Q: Where is it based?
A: At the Trinity Translational Medicine Institute on the St James's Hospital campus in Dublin, working with Tallaght University Hospital, the Coombe and Children's Health Ireland at Crumlin.
Q: What is PMOS?
A: Polyendocrine metabolic ovarian syndrome, the new name for the condition previously called polycystic ovary syndrome (PCOS).
Q: Who funds the centre?
A: No funder or budget was announced at the launch.
Conclusion and Outlook
TCRW gives women's and reproductive health research at Trinity a single home, a ministerial launch and a clear set of priorities, from PMOS and endometriosis to menopause and fertility. The next things to watch are the funding the centre secures, the first studies it coordinates with patient groups, and how quickly its work feeds into clinical practice in Irish hospitals.
Cover image: AI-generated illustration of a research laboratory. It does not show any real person, hospital or institution.
Sources
- Trinity College Dublin, Launch of the Trinity Centre for Reproductive Sciences and Women's Health, 12 October 2026
- TCRW, About the centre
- Irish Medical Times, New research centre to focus on women and reproductive health, 15 October 2026
